Female sex and oral contraceptive use accelerate nicotine metabolism

Several studies have reported that female smokers have a higher risk of lung cancer than male smokers. This could be related to sex differences in nicotine metabolism and related smoking behavior. This study tested the hypothesis that women metabolize nicotine more rapidly than men and that, among women, oral contraceptive users metabolize nicotine more rapidly than nonusers of oral contraceptives.

[1]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[2]  J. McNeil,et al.  Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation , 1994, BMJ.

[3]  S. Schenker,et al.  Effects of oral contraceptive steroids on acetaminophen metabolism and elimination , 1983, Clinical pharmacology and therapeutics.

[4]  P. Jacob,et al.  Pharmacokinetics of (S)-nicotine and metabolites in humans , 1993 .

[5]  D. Hatsukami,et al.  Gender and the Effects of Different Doses of Nicotine Gum on Tobacco Withdrawal Symptoms , 1995 .

[6]  R. Tyndale,et al.  CYP2A6 genetic variation and potential consequences. , 2002, Advanced drug delivery reviews.

[7]  R. Tyndale,et al.  A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. , 1997, The Journal of pharmacology and experimental therapeutics.

[8]  R. Tyndale,et al.  Genetic Variation in CYP2A6-Mediated Nicotine Metabolism Alters Smoking Behavior , 2002, Therapeutic drug monitoring.

[9]  Y. Funae,et al.  Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. , 1996, The Journal of pharmacology and experimental therapeutics.

[10]  E. Sellers,et al.  Gender differences in tobacco smoking: higher relative exposure to smoke than nicotine in women. , 2002, Journal of women's health & gender-based medicine.

[11]  W. Jusko,et al.  Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics , 1996, Clinical pharmacology and therapeutics.

[12]  L. Benet,et al.  Marked alterations in dose‐dependent prednisolone kinetics in women taking oral contraceptives , 1986, Clinical pharmacology and therapy.

[13]  E. Wynder,et al.  Differences in lung cancer risk between men and women: examination of the evidence. , 1996, Journal of the National Cancer Institute.

[14]  M. Thun,et al.  Tobacco use and cancer: an epidemiologic perspective for geneticists , 2002, Oncogene.

[15]  P. Kroboth,et al.  Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics , 1984, Clinical pharmacology and therapeutics.

[16]  O. Miettinen,et al.  Women's susceptibility to tobacco carcinogens. , 2004, Lung cancer.

[17]  P. J. Huber.  The behavior of maximum likelihood estimates under nonstandard conditions , 1967 .

[18]  L. Bertilsson,et al.  No sex‐related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects , 2000, Clinical pharmacology and therapeutics.

[19]  W. Kuhnz,et al.  Influence of ethinylestradiol-containing combination oral contraceptives with gestodene or levonorgestrel on caffeine elimination , 2004, European Journal of Clinical Pharmacology.

[20]  G. Swan,et al.  Pharmacogenetics of Nicotine Metabolism in Twins: Methods and Procedures , 2004, Twin Research.

[21]  N. Benowitz,et al.  Accelerated metabolism of nicotine and cotinine in pregnant smokers. , 2002, The Journal of pharmacology and experimental therapeutics.

[22]  D. Greenblatt,et al.  Impairment of diazepam metabolism by low-dose estrogen-containing oral-contraceptive steroids. , 1982, The New England journal of medicine.

[23]  G. Swan,et al.  Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence , 2005, Pharmacogenetics and genomics.

[24]  L. Heilbronn,et al.  Oral contraceptive steroids impair the elimination of theophylline. , 1983, The Journal of laboratory and clinical medicine.

[25]  N. Benowitz,et al.  Determination of the nicotine metabolite trans-3'-hydroxycotinine in urine of smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring. , 1992, Journal of chromatography.

[26]  N. Benowitz,et al.  Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans. , 1991, Biological mass spectrometry.

[27]  T. Massey,et al.  Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in peripheral human lung microsomes. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[28]  M. M. Ward,et al.  Subgroups of smokers with different success rates after use of transdermal nicotine. , 1997, Addiction.

[29]  E. Perez-stable,et al.  Nicotine metabolism and intake in black and white smokers. , 1998, JAMA.

[30]  Y. Funae,et al.  Role of human cytochrome P4502A6 in C-oxidation of nicotine. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[31]  J. Miners,et al.  Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid. , 1986, British journal of clinical pharmacology.

[32]  A. Buist,et al.  Gender differences in smoking cessation after 3 years in the Lung Health Study. , 1995, American journal of public health.

[33]  D. Hatsukami,et al.  Gender differences in the pharmacology of nicotine addiction , 1998, Addiction biology.

[34]  H. White.  A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity , 1980 .

[35]  N. Benowitz,et al.  Synthesis of optically pure deuterium‐labelled nicotine, nornicotine and cotinine , 1988 .